Industry Leader articles are written by executives at biopharma companies, consultancies, research firms, and companies that provide services or products to sponsors. The topics are nonpromotional and focused on industrywide business issues.
How We Landed In The International Space Station
Looking back, it’s ironic that we named our company LaunchPad Medical. Our inspiration for the name came from our plan to take challenging ideas and materials and “launch” them into the medical space to revolutionize healthcare. But it never dawned on me to take our research to the International Space Station (ISS).
Taking A Strengths-Based Approach To Diversity & Inclusion
Organizations and their leaders often focus on what needs to improve, but research shows there is more to be gained from a strengths-based approach. Coaching around strengths yields greater optimism and success.
6 Tips For Contracting Or Seeking Funding From The Federal Government
With the right preparation and investments, entering the federal government market can lead to considerable growth and visibility for your company. Consider the following tips for increased chances of success.
The Great Regulatory Catch-Up: Shortcuts To Compliance For Medical Devices Manufacturers
The medical device market is about to succumb to a raft of substantial international regulatory changes, starting with Europe’s MDR in May 2020, as public pressure and industry authorities call for greater accountability for patient safety.
A Different Path To An IPO
Typically, there are two paths biotechs take when going public — seeking VC funding or raising capital via a reverse merger. However, INmune Bio chose a third path.
Data Analytics Are Unlocking Valuable Cold-Chain Insights
Much like in many other areas of the drug development continuum, the focus now in the cold chain is on data and how it can be unlocked and analyzed in real time to save money, time, and resources — while also better ensuring patient safety.
Greater Rigor Is Needed To Enable Real-World Evidence To Reach Its Full Potential
As the industry’s appetite for creating and using data-driven insights to improve clinical outcomes continues to grow, so does the need to integrate and validate disparate data sources. Efforts to impose greater consistency and rigor should be welcomed by all.
AI In Life Sciences — Seeing Past The Hype
Life science leaders must balance their need to apply AI technologies to improve patient care, and bottom lines — without getting caught-up in the AI hype machine.
Pitching Investors: It’s About You, Not The Slide Deck
Let’s face it … pitching potential investors is a remarkable opportunity. It could be your one shot at getting your idea or company off the ground, so you better be appealing, tantalizing, and even provocative.
Beyond Capital and Mentoring: Paving The Way For Female Entrepreneurs
Women who are starting life sciences companies often do not have access to a network of mentors and advisors, whose strong advocacy establishes instant credibility and opens the doors to investors.
BEYOND THE PRINTED PAGE
Why Top Researchers And Physicians Enter The World Of Biopharma R&D
David Chang, M.D., Ph.D., founder and CEO of Allogene Therapeutics, along with numerous other physicians have opted to become biopharmaceutical executives, but one doesn’t have to go to medical school to be driven to make a difference for patients.
Genmab’s Commercial Engine Aspirations
Jan G. J. van de Winkel, Ph.D., cofounder and CEO of Genmab, discusses the company’s aspirations to eventually commercialize its own products.
Tariff Wars, Politics, And Other Concerns Of 6 Biopharma CEOs For 2020 And Beyond
Six biopharma CEOs talk tariff wars, politics, and other concerns for 2020 and beyond.
LIFE SCIENCE LEADER BLOGS
Brightspot: How A Biopharma VC Makes A Difference For Orphans
Ed Torres, managing partner at Lilly Ventures, shares how he and his wife got involved in making a difference for U.S. orphans.
The CNS Summit — A Caring Community Of Collaborative Solution Finders
Chief editor Rob Wright explains what differentiates the CNS Summit from other biopharmaceutical industry conferences.